Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.

Esophageal varices in patients with cirrhosis: multidetector CT esophagography--comparison with endoscopy. Radiology (2007) 2.21

Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol (2006) 1.90

Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc (2004) 1.81

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology (2000) 1.24

The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg (2005) 1.21

Portal hypertension and variceal hemorrhage. Med Clin North Am (2008) 1.19

Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ (2006) 1.10

Beta blocker prophylaxis for patients with variceal hemorrhage. J Clin Gastroenterol (2005) 1.08

Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. J Gastroenterol Hepatol (2006) 1.05

Pathophysiology of portal hypertension. J Physiol Pharmacol (2008) 1.04

Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol (2005) 0.96

Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices. Aliment Pharmacol Ther (2009) 0.89

A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci (2005) 0.83

Prevention of the development of varices and first portal hypertensive bleeding episode. Best Pract Res Clin Gastroenterol (2007) 0.81

Management of pre-liver transplantation patient--part 2. Liver Transpl (2005) 0.80